Omicron Variant Could Bring A New Normal For Covid 19

Omicron Variant Could Bring A New Normal For Covid 19
SHARE

USA Today revealed that people are putting up with tens of millions of flu infections, and there are also tens of thousands of deaths. 

The online publication notes that the “respiratory syncytial virus, which mostly affects children and those over 65, causes about 235,000 hospitalizations and 15,000 deaths.”

The same online publication notes that while families can be devastated by these diseases, the majority of people continue to go on, barely paying attention. Check out the interesting question that is posted in  the article of the publication mentioned above. 

“When will we reach that point with the coronavirus, people have often asked over the last two years. What is an acceptable level of sickness, hospitalizations and deaths from COVID-19?”

The same online publication notes that the omicron variant opens the door to this kind of thinking, experts say. This variant of the virus, so far, appears so much milder than delta or the original virus.

The article brings up something that a trio of experts say in the scientific journal JAMA:

“It’s time, however, for public and political leaders to start talking about what levels of disease we would accept.”

The article also notes what an endemic virus looks like and debates more interesting elements. 

“We could have an endemic state where disease burden is still unacceptable, if it stays very severe.”

This is what Elizabeth Halloran, a biostatistician and epidemiologist at the University of Washington and the Fred Hutchinson Cancer Research Center said. 

Source: pixabay.com

Omicron could change the new normal, according to the notes which we strongly recommend that you check out. 

FDA and Pfizer controversy

There has been a massive scandal involving the fact that the FDA asked for 75 years to produce Pfizer vaccine safety data. Now, it seems that things are changing and you should check out the latest reports on the issue below.

It’s been just reported that the U.S. Food and Drug Administration (FDA) will have eight months — not the 75 years it requested — to release all documents related to the licensing of Pfizer’s Comirnaty covid vaccine. This is what a federal judge ruled Thursday.


SHARE
Rada Mateescu

Passionate about subjects from the science and health-related areas, Rada has been blogging for about ten years and at Health Thoroughfare, she's covering the latest news on these niches.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.